149.14 USD
-2.76 (-1.82%)
149.14 USD
0 (0%)
Overall ICUI gets a fundamental rating of 4 out of 10. We evaluated ICUI against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ICUI was profitable.
In the past year ICUI had a positive cash flow from operations.
In multiple years ICUI reported negative net income over the last 5 years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI's Return On Assets of -0.18% is fine compared to the rest of the industry. ICUI outperforms 72.34% of its industry peers.
With a decent Return On Equity value of -0.35%, ICUI is doing good in the industry, outperforming 72.87% of the companies in the same industry.
ICUI has a Return On Invested Capital of 2.86%. This is in the better half of the industry: ICUI outperforms 70.74% of its industry peers.
ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.71%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI has a Operating Margin of 5.63%. This is in the better half of the industry: ICUI outperforms 70.74% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI's Gross Margin of 36.47% is on the low side compared to the rest of the industry. ICUI is outperformed by 69.15% of its industry peers.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
ICUI has an Altman-Z score of 2.26. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, ICUI is in the better half of the industry, outperforming 63.30% of the companies in the same industry.
The Debt to FCF ratio of ICUI is 21.21, which is on the high side as it means it would take ICUI, 21.21 years of fcf income to pay off all of its debts.
ICUI has a Debt to FCF ratio of 21.21. This is in the better half of the industry: ICUI outperforms 69.15% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that ICUI is somewhat dependend on debt financing.
The Debt to Equity ratio of ICUI (0.62) is worse than 64.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.38
WACC7.51%
2.3 Liquidity
A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.45, ICUI is in line with its industry, outperforming 47.34% of the companies in the same industry.
A Quick Ratio of 1.19 indicates that ICUI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.19, ICUI is doing worse than 69.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.14% over the past year.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.28% on average per year.
ICUI shows a decrease in Revenue. In the last year, the revenue decreased by -0.84%.
The Revenue has been growing by 13.47% on average over the past years. This is quite good.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
Based on estimates for the next years, ICUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.18% on average per year.
Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 1.96% on average per year.
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.74, ICUI is valued on the expensive side.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 82.98% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.98, ICUI is valued a bit cheaper.
The Price/Forward Earnings ratio is 18.16, which indicates a rather expensive current valuation of ICUI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 81.38% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ICUI to the average of the S&P500 Index (35.79), we can say ICUI is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.74 | ||
| Fwd PE | 18.16 |
4.2 Price Multiples
84.04% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
72.87% of the companies in the same industry are more expensive than ICUI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.17 | ||
| EV/EBITDA | 14.3 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICUI's earnings are expected to grow with 15.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y14.9%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
149.14
-2.76 (-1.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners113.8%
Inst Owner Change3.93%
Ins Owners0.98%
Ins Owner Change-1.79%
Market Cap3.68B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (24.06%)
Short Float %6.31%
Short Ratio5.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)2.02%
PT rev (3m)2.95%
EPS NQ rev (1m)-0.97%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.74 | ||
| Fwd PE | 18.16 | ||
| P/S | 1.59 | ||
| P/FCF | 59.17 | ||
| P/OCF | 23.1 | ||
| P/B | 1.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.3 |
EPS(TTM)7.96
EY5.34%
EPS(NY)8.21
Fwd EY5.51%
FCF(TTM)2.52
FCFY1.69%
OCF(TTM)6.46
OCFY4.33%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)1.28
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.26 |
F-Score7
WACC7.51%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year37.73%
EBIT Next 3Y15.54%
EBIT Next 5Y10.05%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 14.6% in the next year.